Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported Licence

Total synthesis of (±)-3-demethoxyerythratidinone via Tf2O-promoted cascade reaction of enaminone

Mingliang Lou a, Xiaolei Liu b, Shoule Han ac, Songlin Bai ad and Xiangbing Qi *ac
aNational Institute of Biological Sciences (NIBS), Beijing 102206, China
bInstitute for Smart Materials & Engineering, School of Chemistry and Chemical Engineering, University of Jinan, Jinan 250022, Shandong, China
cTsinghua Institute of Multidisciplinary Biomedical Research, Tsinghua University, Beijing 100084, China. E-mail: qixiangbing@nibs.ac.cn
dSchool of Life Sciences, Tsinghua University, Beijing 100084, China

Received 4th January 2024 , Accepted 8th March 2024

First published on 12th March 2024


Abstract

The tetracyclic rings with chiral quaternary center represent a formidable synthetic challenge for Erythrina alkaloids. We present a 6-step synthesis of the Erythrina alkaloid 3-demethoxyerythratidinone with a 16% overall yield. Our synthesis highlights a cascade reaction initiated by Tf2O-induced activation of an enaminone substrate, yielding an iminium species and an enol triflate, followed by a Pictet–Spengler reaction. This method efficiently constructs the tetracyclic core skeleton, featuring an N-substituted quaternary center. It exhibits versatility across diverse (hetero)arenes and enaminone structures, providing a general strategy for the rapid synthesis of fused or spiro ring systems including the core structure of homoerythrina alkaloids.


Erythrina and homoerythrina alkaloids represent a diverse class of natural products possessing a broad range of biological activities including hypotensive, sedative, hypnotic, and CNS effects.1 Structurally, these alkaloids are characterized by a tetracyclic ring system comprising a hydroindole moiety with an N-substituted quaternary stereocenter (Fig. 1a). As a representative member of the Erythrina alkaloids, 3-demethoxyerythratidinone (3) frequently serves as a model compound for innovative synthetic strategies aimed at constructing complex tetracyclic ring systems.2
image file: d3cc06270h-f1.tif
Fig. 1 Representative Erythrina and homoerythrina alkaloids and our reaction design.

Enaminones are versatile intermediates in chemical synthesis,3 and functionalization of enaminones via Tf2O-induced activation to form iminiums 10 followed by nucleophilic attacks at C3 has been extensively studied (Fig. 1c).4 However, unlike the use of Tf2O for amide activation (Fig. 1b),5 wherein in situ generated iminiums 7 are intra- and intermolecularly trapped to construct pivotal building blocks and intricate ring systems, the trapping of Tf2O-induced enaminone-derived iminiums at C1 remains less developed.4a–c Furthermore, to the best of our knowledge, there is no report on the Tf2O-induced activation of enaminones followed by a Pictet–Spengler cascade reaction for construction of complex ring systems (Fig. 1c).

Our sustained interest in synthesizing natural products featuring hydroindole skeletons via an indole-hydrogenation strategy6 led us to envisage construction of the tetracyclic ring system of Erythrina alkaloids from amide 17a, which encompassed the A, B, and D rings in 1 (Scheme 1). Commencing with the chemoselective hydrogenation of 4-hydroxyindole 14,6a we obtained enaminone 15, which, upon condensation with 2-(3,4-dimethoxyphenyl)acetic acid 16, yielded 17a. We envisioned that the enaminone motif within 17a could be activated by Tf2O to give iminium 18, which is further converted to the tetracyclic compound 19avia an intramolecular Pictet–Spengler reaction. There are several salient features of this designed cascade reaction to be noted: (1) a tetracyclic ring system with an N-substituted quaternary center (C5) can be constructed in a single step; (2) the enol triflate can not only serve as versatile handles for further modification via transition metal-catalyzed cross-coupling reactions but also facilitate the construction of an alkene characteristic of Erythrina alkaloids that is hard to install regioselectively as demonstrated in previous studies;6a,7 (3) variation of the enaminone, the arene ring, or the linker between them can lead to a variety of ring systems, for example, the core skeleton of homoerythrina alkaloids (2).


image file: d3cc06270h-s1.tif
Scheme 1 Our strategy for construction of the tetracyclic core skeleton.

Herein, we describe the development of a cascade reaction leveraging Tf2O-promoted activation of enaminones followed by intramolecular Pictet–Spengler reactions to construct complex ring systems and the successful application of this method to the total synthesis of the Erythrina alkaloid 3-demethoxyerythratidinone (3).

The investigation commenced by subjecting enaminone 17a to Tf2O (2.0 equiv.) in DCM (0.2 M) at room temperature for 24 h. Encouragingly, while residual 17a remained, the isolated yield of the desired product 19a reached 62% (Table 1, entry 1). Raising the reaction temperature to 35 °C resulted in the complete consumption of 17a and an increased yield of 73% (entry 2). However, further elevation of the temperature did not enhance the yield (entry 3). Alternative solvents explored instead of DCM did not give satisfactory results (entries 4–7). Unlike prior studies on Tf2O-induced activation of amides and enones,5a–d,8 the introduction of bases adversely affected the yield (entries 8–10). Additionally, subjecting 17a to Tf2O at −78 °C for 1 h followed by heating at 35 °C for 24 h did not increase the yield (entry 11). Remarkably, scaling the reaction to a gram-scale did not significantly impact the yield (entry 12). Notably, attempts to employ Comins’ reagent, N-phenyl-bis(trifluoromethanesulfonimide), trifluoroacetic anhydride, or acetic anhydride in place of Tf2O did not yield corresponding products.

Table 1 Optimization of the reaction conditionsa

image file: d3cc06270h-u1.tif

Entry Solvent T (°C) Yield (%)b
a Reaction conditions: 17a (0.2 mmol, 1.0 equiv.), Tf2O (2.0 equiv.), DCM (0.2 M), sealed tube, r.t. for 0.5 h then 35 °C for 24 h. b Isolated yields. c 2-Chloropyridine (1.05 equiv.) was added. d N,N-Diisopropylethylamine (1.05 equiv.) was added. e 2,6-Di-tert-butyl pyridine (1.05 equiv.) was added. f Gram-scale reaction.
1 DCM 25 62
2 DCM 35 73
3 DCM 45 67
4 1,2-DCE 35 62
5 Toluene 70 54
6 CH3CN 35 50
7 CH3NO2 35 19
8 DCM 35 40c
9 DCM 35 25d
10 DCM 35 <10e
11 DCM −78–35 66
12 DCM 35 66f


With the optimized reaction conditions established (Table 1, entry 2), we proceeded to investigate the substrate scope of this cascade reaction (Fig. 2). Arene substrates bearing electron-donating groups exhibited notable compatibility (19a19c), whereas those with electron-withdrawing groups, such as Br and I, demonstrated limited suitability. And a higher reaction temperature was required for less electron-rich arenes (19c). Moreover, the reaction displayed compatibility with various electron-rich heteroarenes (19d19g). Employing a substrate containing an N-Me-protected indole ring required an initial stirring at −78 °C for 1 h followed by stirring at −20 °C for an additional 24 h to achieve an improved yield of 19f. We speculated that the enaminone could be activated by Tf2O at −78 °C and the subsequent Pictet–Spengler reaction took place at −20 °C to give 19f. If the substrate was initially treated with Tf2O at a relatively high temperature, the electron-rich indole ring with high nucleophilicity may interrupt the enaminone activation process thus leading to undesired results.


image file: d3cc06270h-f2.tif
Fig. 2 Substrate scope. Isolated yields are given. a[thin space (1/6-em)]Reaction mixture in a sealed tube was stirred at r.t. for 0.5 h before being stirred at corresponding temperature for 24 h. b[thin space (1/6-em)]Reaction mixture in a sealed tube was stirred at -78 °C for 1 h before being stirred at corresponding temperature for 24 h. c[thin space (1/6-em)]The reaction time was 48 h.

Our pursuit of synthesizing indole alkaloids led us to synthesize a diverse array of substrates featuring indole rings with varied substitution patterns,6 all yielding the desired products in moderate yields (19h19m). To our delight, this method proved versatile not only for constructing six-membered rings as observed in 19a19m but also for synthesizing five (19n) and seven-membered (19o) rings. Notably, compound 19o embodies the tetracyclic skeleton 2 characteristic of homoerythrina alkaloids. Furthermore, beyond enaminone 15-derived compounds, substrates featuring diverse enaminone structures were amenable to this cascade reaction, yielding compounds 19p19t, with the structural elucidation of 19p (CCDC 2336176) and 19q (CCDC 2034445) being accomplished through X-ray diffraction analysis. Notably, compound 19a could be smoothly hydrolysed to give compound 20, with establishment of another stereocenter.9

To demonstrate the synthetic potential of this cascade reaction, we carried out the total synthesis of 3-demethoxyerythratidinone (3). Removal of the OTf group in 19a under palladium-catalyzed reductive conditions yielded 21 (Scheme 2).10 Subsequent reduction of lactam 21 with LiAlH4/CeCl3 afforded 22, a potential precursor for allylic oxidation to give 3. However, SeO2 mediated Riley oxidation selectively produced α-ketone lactam 23 (Table 2, entry 1), possibly arising from 22 through benzylic oxidation followed by further oxidation of the α methylene of the newly generated ketone. Palladium-catalyzed oxidation conditions gave unidentified mixtures (entry 2).11 Copper-catalyzed oxidation conditions led to overoxidized product 24 (entry 3),12 which holds promise as an intermediate for synthesizing natural product 10,11-dioxoerythratidinone (4). Under the PDC/TBHP condition, both 23 and 24 were observed (entry 4).13 Finally, employing the CrO3/3,5-dimethylpyrazole oxidation condition at −20 °C yielded 3 (entry 5), whereas raising the temperature to room temperature furnished 24 (entry 6).14 The spectroscopic data of 3 were identical to the reported data.2p Therefore, we completed the total synthesis of 3 in 6 steps with an overall yield of 16% from commercially available 4-hydroxyindole.


image file: d3cc06270h-s2.tif
Scheme 2 Total synthesis of 3-demethoxyerythratidinone 3.
Table 2 Optimization of the allylic oxidation conditions

image file: d3cc06270h-u2.tif

Entry Conditions Productsa
a Major products detected by 1H NMR and UPLC-MS are given. b Reaction was messy. TBHP, tert-butyl hydroperoxide; PDC, pyridinium dichromate.
1 SeO2, 100 °C 23
2 Pd/C, TBHP, 0 °C b
3 CuI/TBHP, r.t. or 50 °C 24
4 PDC/TBHP, 0 °C to r.t. 23 and 24
5 CrO3/3,5-dimethylpyrazole, −20 °C 3
6 CrO3/3,5-dimethylpyrazole, −20 °C–r.t. 24


In conclusion, we have developed a cascade reaction involving Tf2O-promoted activation of enaminones followed by intramolecular trapping of the iminium intermediates with (hetero)arenes. Combinations of a wide range of enaminones and (hetero)arenes can lead to products with complex fused or spiro ring systems. This method was successfully applied to the total synthesis of the Erythrina alkaloid 3-demethoxyerythratidinone (3). Further applications of this method to the total synthesis of other natural products are currently being explored in our group.

This work was supported by the National Natural Science Foundation of China (21971018 and 82225041). The authors gratefully acknowledge the Beijing Municipal Government and Tsinghua University for the financial support.

Conflicts of interest

There are no conflicts to declare.

Notes and references

  1. (a) S. F. Dyke and S. N. Quessy, in The Alkaloids, ed. R. R. G. A., Academic, New York, 1981, vol. 18, ch. 1, pp. 1–98 Search PubMed; (b) E. Reimann, in Progress in the Chemistry of Organic Natural Products, ed. W. Herz, H. Falk and G. W. Kirby, Springer, Vienna, 2007, Vol. 88, ch. 1, pp. 1–62 Search PubMed.
  2. (a) F. Zhang, N. S. Simpkins and C. Wilson, Tetrahedron Lett., 2007, 48, 5942–5947 CrossRef CAS; (b) F. Zhang, N. S. Simpkins and A. J. Blake, Org. Biomol. Chem., 2009, 7, 1963–1979 RSC; (c) K. V. Chuang, R. Navarro and S. E. Reisman, Chem. Sci., 2011, 2, 1086–1089 RSC; (d) M. Paladino, J. Zaifman and M. A. Ciufolini, Org. Lett., 2015, 17, 3422–3425 CrossRef CAS PubMed; (e) R. Q. Xu, P. Yang, C. Zheng and S. L. You, Chin. J. Chem., 2020, 38, 683–689 CrossRef CAS; (f) H. Tanaka, M. Shibata and K. Ito, Chem. Pharm. Bull., 1984, 32, 1578–1582 CrossRef CAS; (g) Y. Tsuda and A. Nakai, Heterocycles, 1984, 22, 1817–1820 CrossRef CAS; (h) S. J. Danishefsky and J. S. Panek, J. Am. Chem. Soc., 1987, 109, 917–918 CrossRef CAS; (i) H. Irie, K. Shibata, K. Matsuno and Y. Zhang, Heterocycles, 1989, 29, 1033–1035 CrossRef CAS; (j) H. H. Wasserman and R. M. Amici, J. Org. Chem., 1989, 54, 5843–5844 CrossRef CAS; (k) H. Ishibashi, T. Sato, M. Takahashi, M. Hayashi, K. Ishikawa and M. Ikeda, Chem. Pharm. Bull., 1990, 38, 907–911 CrossRef CAS; (l) J. Cassayre, B. Quiclet-Sire, J. B. Saunier and S. Z. Zard, Tetrahedron Lett., 1998, 39, 8995–8998 CrossRef CAS; (m) Q. Wang and A. Padwa, Org. Lett., 2006, 8, 601–604 CrossRef CAS PubMed; (n) J. M. Joo, R. A. David, Y. Yuan and C. Lee, Org. Lett., 2010, 12, 5704–5707 CrossRef CAS PubMed; (o) R. Q. Xu, Q. Gu, W. T. Wu, Z. A. Zhao and S. L. You, J. Am. Chem. Soc., 2014, 136, 15469–15472 CrossRef CAS PubMed; (p) H. T. Luu, S. Wiesler, G. Frey and J. Streuff, Org. Lett., 2015, 17, 2478–2481 CrossRef CAS PubMed; (q) E. E. Blackham and K. I. Booker-Milburn, Angew. Chem., Int. Ed., 2017, 56, 6613–6616 CrossRef CAS PubMed; (r) S. M. Allin, G. B. Streetley, M. Slater, S. L. James and W. P. Martin, Tetrahedron Lett., 2004, 45, 5493–5496 CrossRef CAS; (s) J. T. Moon, J. A. Jung, S. H. Ha, S. H. Song, S. J. Park, J. Kim, D. J. Choo, Y. S. Lee and J. Y. Lee, Synth. Commun., 2011, 41, 1282–1292 CrossRef CAS; (t) S. Chikaoka, A. Toyao, M. Ogasawara, O. Tamura and H. Ishibashi, J. Org. Chem., 2003, 68, 312–318 CrossRef CAS PubMed; (u) S. Gao, Y. Q. Tu, X. Hu, S. Wang, R. Hua, Y. Jiang, Y. Zhao, X. Fan and S. Zhang, Org. Lett., 2006, 8, 2373–2376 CrossRef CAS PubMed; (v) G. Kim, J. H. Kim and K. Y. Lee, J. Org. Chem., 2006, 71, 2185–2187 CrossRef CAS PubMed; (w) J. Liang, J. Chen, J. Liu, L. Li and H. Zhang, Chem. Commun., 2010, 46, 3666–3668 RSC; (x) Z. Q. Pan, J. X. Liang, J. B. Chen, X. D. Yang and H. B. Zhang, Nat. Prod. Bioprospect., 2011, 1, 129–133 CrossRef CAS; (y) S. T. Heller, T. Kiho, A. R. H. Narayan and R. Sarpong, Angew. Chem., Int. Ed., 2013, 52, 11129–11133 CrossRef CAS PubMed.
  3. (a) A. Z. A. Elassar and A. A. El-Khair, Tetrahedron, 2003, 59, 8463–8480 CrossRef CAS; (b) G. Negri, C. Kascheres and A. J. Kascheres, J. Heterocyclic Chem., 2004, 41, 461–491 CrossRef CAS.
  4. (a) B. Singer and G. Maas, Chem. Ber., 1987, 120, 1683–1690 CrossRef CAS; (b) B. Singer and G. Maas, Chem. Ber., 1987, 120, 485–495 CrossRef CAS; (c) T. Mayer and G. Maas, Synlett, 1990, 399–400 CrossRef CAS; (d) F. Krebs and G. Maas, Synthesis, 1989, 735–738 CrossRef CAS; (e) T. G. Back and K. Nakajima, J. Org. Chem., 1998, 63, 6566–6571 CrossRef CAS.
  5. (a) K. J. Xiao, J. M. Luo, K. Y. Ye, Y. Wang and P. Q. Huang, Angew. Chem., Int. Ed., 2010, 49, 3037–3040 CrossRef CAS PubMed; (b) K. J. Xiao, Y. Wang, K. Y. Ye and P. Q. Huang, Chem. – Eur. J., 2010, 16, 12792–12796 CrossRef CAS PubMed; (c) M. Movassaghi and M. D. Hill, J. Am. Chem. Soc., 2006, 128, 14254–14255 CrossRef CAS PubMed; (d) M. Movassaghi, M. D. Hill and O. K. Ahmad, J. Am. Chem. Soc., 2007, 129, 10096–10097 CrossRef CAS PubMed; (e) D. Kaiser, A. Bauer, M. Lemmerer and N. Maulide, Chem. Soc. Rev., 2018, 47, 7899–7925 RSC.
  6. (a) X. Liu, M. Lou, S. Bai, G. Sun and X. Qi, J. Org. Chem., 2022, 87, 5199–5212 CrossRef CAS PubMed; (b) S. Han, M. Lou and X. Qi, Synlett, 2024, 35, 586–592 CrossRef CAS.
  7. R. Ahmed-Schofield and P. S. Mariano, J. Org. Chem., 1987, 52, 1478–1482 CrossRef CAS.
  8. M. A. Grundl, A. Kaster, E. D. Beaulieu and D. Trauner, Org. Lett., 2006, 8, 5429–5432 CrossRef CAS PubMed.
  9. We thank the reviewer for the constructive advice on this transformation.
  10. R. T. Larson, M. D. Clift and R. J. Thomson, Angew. Chem., Int. Ed., 2012, 51, 2481–2484 CrossRef CAS PubMed.
  11. J. Q. Yu and E. J. Corey, Org. Lett., 2002, 4, 2727–2730 CrossRef CAS PubMed.
  12. J. A. R. Salvador, M. L. S. Melo and A. S. C. Neves, Tetrahedron Lett., 1997, 38, 119–122 CrossRef CAS.
  13. N. Chidambaram and S. Chandrasekaran, J. Org. Chem., 1987, 52, 5048–5051 CrossRef CAS.
  14. W. G. Salmond, M. A. Barta and J. L. Havens, J. Org. Chem., 1978, 43, 2057–2059 CrossRef CAS.

Footnote

Electronic supplementary information (ESI) available. CCDC 2034445 and 2336176. For ESI and crystallographic data in CIF or other electronic format see DOI: https://doi.org/10.1039/d3cc06270h

This journal is © The Royal Society of Chemistry 2024
Click here to see how this site uses Cookies. View our privacy policy here.